Green MR - Search Results

1

Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data.

Green MR, Andrews M, Leff R, Willey J, Allegra C, Denes A, Epstein J, Jones J, Lokey L. Green MR, et al. J Oncol Pract. 2005 Jul;1(2):37-42. doi: 10.1200/JOP.2005.1.2.37. J Oncol Pract. 2005. PMID: 20871677 Free PMC article.

2

Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.

Green MR, Dowlati A, Yellamraju L, Daniels L, Willey J, Andrews M, Leff R. Green MR, et al. J Thorac Oncol. 2007 Oct;2(10):953-6. doi: 10.1097/JTO.0b013e318153f8db. J Thorac Oncol. 2007. PMID: 17909359 Free article.

3

How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.

Dornbusch D, Allegra C, Willey J, Andrews M, Leff R, Epstein J, Jones J, Lokey L, Green MR. Dornbusch D, et al. Among authors: green mr. Oncologist. 2006 Jan;11(1):31-8. doi: 10.1634/theoncologist.11-1-31. Oncologist. 2006. PMID: 16401711 Free article.

4

Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancer.

Green MR, West H, Socinski MA, Willey J, Daniels L, Lemke K, Rafferty G, Iovino L. Green MR, et al. J Thorac Oncol. 2009 Aug;4(8):983-7. doi: 10.1097/JTO.0b013e3181adeefb. J Thorac Oncol. 2009. PMID: 19561551 Free article.

5

First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices.

Lunacsek OE, Ravelo A, Coutinho AD, Hazard SJ, Green MR, Willey J, Eaddy M, Goertz HP. Lunacsek OE, et al. Among authors: green mr. Drugs Real World Outcomes. 2016 Sep;3(3):333-343. doi: 10.1007/s40801-016-0090-5. Drugs Real World Outcomes. 2016. PMID: 27747837 Free PMC article.

6

Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.

Green MR. Green MR. J Clin Oncol. 2008 Jul 1;26(19):3112-3. doi: 10.1200/JCO.2007.15.7446. J Clin Oncol. 2008. PMID: 18591551 No abstract available.

7

A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).

McClay EF, Bogart J, Herndon JE 2nd, Watson D, Evans L, Seagren SL, Green MR; Cancer and Leukemia Group B Study (9235). McClay EF, et al. Among authors: green mr. Am J Clin Oncol. 2005 Feb;28(1):81-90. doi: 10.1097/01.coc.0000139940.52625.d0. Am J Clin Oncol. 2005. PMID: 15685040 Clinical Trial.

8

Overview of MTA in the treatment of non-small cell lung cancer.

Postmus PE, Green MR. Postmus PE, et al. Among authors: green mr. Semin Oncol. 1999 Feb;26(1 Suppl 4):31-6. Semin Oncol. 1999. PMID: 10201519 Review.

9

Radiation and chemotherapy for patients with stage III non-small cell lung cancer.

Green MR, Rocha Lima CM, Sherman CA. Green MR, et al. Semin Radiat Oncol. 2000 Oct;10(4):289-95. doi: 10.1053/srav.2000.9611. Semin Radiat Oncol. 2000. PMID: 11040329 Review.

10

Advances in the treatment of non-small cell lung cancer: molecular markers take the stage.

Rosell R, Green M, Gumerlock P. Rosell R, et al. Semin Oncol. 2001 Feb;28(1 Suppl 2):28-34. Semin Oncol. 2001. PMID: 11284622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

900 results

Search Page

Filters